Explore the key hurdles to anticipating the initial and potential value of the NASH therapy market:
• See how lack of marketed analogs and uncertainty over surrogate endpoints relevance complicates NASH pricing
• Compare potential manufacturer pricing strategies
• Weigh how payers’ response to prohibitively high costs in the past will play out today
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.
Contact us for product technical and account support.
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: